Eli Lilly to use GLP-1 windfall to fund M&A and diversify pipeline

Jacob Van Naarden is busy.  In addition to running Eli Lilly‘s oncology business, he’s now responsible for finding the drugmaker’s next opportunities as head of business development. And Lilly, now the world’s largest pharmaceutical company, is hungrier than ever for deals.  “The company’s financial strength right now, driven mostly by the weight loss business, is…

Read More

Macy’s (M) earnings Q1 2026

Macy’s posted its strongest fiscal first-quarter comparable sales performance in four years on Wednesday, as the legacy department store’s turnaround continues to show progress.  Led by the 200 so-called reimagined stores Macy’s has upgraded, comparable sales grew 3% overall during the quarter and 1.6% at its namesake banner.   At Bloomingdale’s, comparable sales grew 10.2%, helped…

Read More